XellSmart

About:

Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments.

Website: http://www.xellsmart.com

Top Investors: Eli Lilly, Qiming Venture Partners, HongShan, Tao Capital Partners, Oriza Holdings

Description:

Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China.

Total Funding Amount:

177M CNY

Headquarters Location:

Minhang, Shanghai, China

Founded Date:

2021-01-01

Contact Email:

hr(AT)xellsmart.com

Founders:

Xiang Li

Number of Employees:

101-250

Last Funding Date:

2024-10-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai